The heart responds to the increased stress caused by chronically raised blood pressure, for example, by thickening its wall muscle. In the late stage of this condition, a risk of heart failure arises. Scientists from the ...
Mar 26, 2013
0
0
A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and led by Dr. Guadalupe Sabio has identified a key role for the MKK3/6–p38γ/δ signaling pathway in the development of ...
Aug 16, 2022
0
9
(HealthDay)—For patients with lumbar spondylosis or spondylolisthesis of the lowest lumbar levels who undergo open anterior lumbar interbody fusion (ALIF), use of recombinant human bone morphogenetic protein-2 (rhBMP-2) ...
Dec 29, 2012
0
0
In cardiac hypertrophy, metabolic energy reserves in the heart are depleted, which is thought to contribute to the subsequent development of heart failure. The primary energy source in the heart relies on fatty acid oxidation ...
Feb 25, 2016
0
27
When the heart is subjected to stress, such as high blood pressure, it responds by expanding, both at the level of the whole organ and some of its chambers, and also at the level of single cells. Although the swelling of ...
Oct 31, 2016
0
4
(HealthDay) -- Hypertrophy is present in the majority of patients with port-wine stains (PWS) who are over the age of 50 years, according to a study published online July 2 in the Journal of the American Academy of Dermatology.
Jul 13, 2012
0
0
New research carried out at the University of Dundee has led to the possibility of using an old drug to help prevent the biggest cause of death in Type II diabetes patients.
Aug 29, 2013
0
1
(Medical Xpress)—Miniature human hearts that beat of their own accord are being grown by scientists at Abertay University.
Jun 26, 2014
0
0
Exposure to high levels of traffic-related air pollution is associated with changes in the right ventricle of the heart that may contribute to the known connection between air pollution exposure and heart disease, according ...
Mar 7, 2014
0
0
A research group has found that FGF21, an endocrine factor which reduces glucose levels, protects against cardiac diseases in mice. The research, published online on the journal Nature Communications, was led by Francesc ...
Jun 18, 2013
0
0
